In vivo experiments discovered that treating various head and neck squamous cell carcinoma (HNSCC) cell lines with the highly selected MOR agonist DAMGO significantly increased cell proliferation, colony formation, invasion and migration, and promoted tumor growth.25 The gene discussed is OPRM1; the disease is head and neck squamous cell carcinoma.